Equities

Vicplas International Ltd

Vicplas International Ltd

Actions
Health CareMedical Equipment and Services
  • Price (SGD)0.114
  • Today's Change0.00 / 0.00%
  • Shares traded-1.00
  • 1 Year change-33.72%
  • Beta0.6878
Data delayed at least 10 minutes, as of May 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Vicplas International Ltd is a Singapore-based holding company. The Company operates through two segments: Medical devices and Pipes & pipe fittings. Its Medical devices segment designs, develops and manufactures sterile and non-sterile medical devices. It operates Medical devices segment, through its subsidiaries, Forefront Medical Technology (Pte) Ltd, Forefront Medical Investment Pte. Ltd. and XentiQ (Pte.) Ltd. in Singapore; Forefront (Xiamen) Medical Devices Co., Ltd and Forefront Medical Technology (Jiangsu) Co., Ltd in China; and Arrow Medical Limited in the United Kingdom. Its Pipes & pipe fittings segment manufactures and distributes piping systems for industries, including waste and potable water systems for residential homes, schools, commercial and industrial buildings, and underground electrical systems. It operates Pipes & pipe fittings segment, through its wholly owned subsidiaries, Vicplas Holdings Pte Ltd in Singapore and Rimplas Industries Sdn. Bhd. in Malaysia.

  • Revenue in SGD (TTM)113.86m
  • Net income in SGD1.96m
  • Incorporated1998
  • Employees--
  • Location
    Vicplas International Ltd35 Joo Koon Circle 629110SingaporeSGP
  • Phone+65 62623888
  • Fax+65 63493877
  • Websitehttps://www.vicplas.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Arts Optical International Holdings Ltd206.41m8.86m54.65m3.70k6.170.58453.450.26480.13290.13293.101.401.015.303.20323,326.804.79-7.5110.18-13.8931.0125.184.74-8.380.921973.320.0383--4.560.005-55.28--21.11--
Broncus Holding Corp13.82m-37.85m55.49m308.00--0.2221--4.02-0.449-0.4490.16392.750.04910.67241.11260,024.20-13.45---14.00--70.47---273.93--18.34--0.0125--8.95---0.1962------
Kowa Co Ltd55.47m6.15m57.02m7.87k8.562.337.011.03153.77153.771,379.57563.731.282.757.56--14.506.0623.769.1046.1146.3711.295.390.974913.790.27522.992.167.1962.08---10.57--
Rainmed Medical Ltd13.67m-21.62m57.43m354.00--0.5973--4.20-0.1073-0.10730.06780.47710.11592.8438.14223,754.80-18.53---20.37--66.31---159.88--8.77--0.037---12.42--91.39------
Vicplas International Limited113.86m1.96m58.32m--30.320.75986.580.51220.00380.00380.21970.1500.90612.872.78--1.566.362.088.3751.5153.401.726.001.633.820.284734.64-1.2212.97-52.053.20-4.09-9.71
Yamashita Health Care Holdings Inc535.71m5.72m59.98m570.0010.490.82468.020.112258.51258.5124,234.433,288.822.5717.485.52108,496,500.002.721.947.505.6113.6311.821.060.70731.05--0.003635.555.53-0.1702-68.54-0.14623.4513.05
Itama Ranoraya PT58.85m439.39k64.37m221.00122.801.5654.621.093.883.88450.91304.550.77684.731.903,150,696,000.000.57998.711.1014.9619.5019.670.74667.171.111.340.3441---7.6021.26-89.17-30.5935.00--
Data as of May 15 2024. Currency figures normalised to Vicplas International Ltd's reporting currency: Singapore Dollar SGD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.